Ovatech Plans Pivotal Trial For Non-Hormonal Contraceptive Ring
This article was originally published in The Gray Sheet
Executive Summary
Ovatech aims to begin a pivotal trial in April for its Ovaprene non-hormonal intravaginal silicone ring barrier contraceptive, pending FDA clearance of an investigational device exemption, the company said.